John Varian - Jan 1, 2022 Form 4 Insider Report for ACORDA THERAPEUTICS INC (ACOR)

Role
Director
Signature
/s/ John Varian
Stock symbol
ACOR
Transactions as of
Jan 1, 2022
Transactions value $
$0
Form type
4
Date filed
1/4/2022, 03:22 PM
Next filing
Feb 1, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACOR Non-Employee Stock Option Award $0 +20K $0.00 20K Jan 1, 2022 Common Stock 20K $2.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in four equal quarterly installments over 12 months with the first quarterly installment vesting on April 1, 2022.